Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 3

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 3
---
 |  8 |
| Description                                              
 of Debt Securities                                       | 19 |
| Legal                                                    
 Ownership of Securities                                  | 30 |
| Certain                                                  
 Provisions of Maryland Law and of Our Charter and Bylaws | 33 |
| Material                                                 
 U.S. Federal Income Tax Considerations                   | 38 |
| Plan                                                     
 of Distribution                                          | 66 |
| Legal                                                    
 Matters                                                  | 69 |
| Experts                                                  | 69 |

You should rely only on the information contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus and any applicable free writing prospectus. We have not, and the underwriters have not, authorized anyone to provide you with different information. If anyone provides you with different or additional information, you should not rely on it. This prospectus supplement and the accompanying prospectus are an offer to sell only the securities offered by these documents and only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus supplement, the accompanying prospectus or any applicable free writing prospectus or incorporated by reference in these documents is current only as of the respective dates of those documents or the dates that are specified therein. Our business, financial condition, liquidity, results of operations and prospects may have changed since those dates.

<div align='center'>S-i

ABOUT THIS PROSPECTUS SUPPLEMENT</div>

This document consists of two parts. The first
part is this prospectus supplement, which describes the specific terms of the offering and also adds to and updates information contained
in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus.
The second part is the accompanying prospectus, which gives more general information, some of which may not apply to the Series B
Preferred Stock we are offering. If the information set forth in this prospectus supplement differs in any way from the information set
forth in the accompanying prospectus or documents incorporated by reference herein or therein prior to the date of this prospectus supplement,
you should rely on the information set forth in this prospectus supplement. In addition, to the extent any information incorporated by
reference in this prospectus supplement or the accompanying prospectus from a filing we make with the Securities and Exchange Commission
(the “SEC”) after the date of this prospectus supplement adds to, updates or changes information contained in this prospectus
supplement, the accompanying prospectus or an earlier filing we made with the SEC that is incorporated by reference in this prospectus